Acquisition of Consultech Strengthens Omnicom's Presence in China's Growing
Healthcare Market
BEIJING, Sept. 3 /PRNewswire-FirstCall/ -- Omnicom Group Inc. ("Omnicom") (NYSE: OMC), the leading global advertising and marketing services group, has acquired, through its Diversified Agency Services division ("DAS"), a majority ownership interest in Consultech, a leading healthcare market consulting and marketing communications company based in China.
With offices in Beijing and Shanghai, Consultech offers a wide range of marketing services to multinational and local healthcare companies covering strategic consulting, marketing research, marketing communications and advertising. Consultech's clients include Novartis, Novo Nordisk, Xian- Janssen, Ipsen and China Resources Corp.
"Through Consultech joining Omnicom, we have strengthened our ability to deliver a full scope of services to our healthcare clients in China," said David Stark, President & CEO of DAS Asia-Pacific Healthcare. "During 2007 we have already seen strong growth in our healthcare footprint in China through our association with Consultech. Moreover, Consultech's solid healthcare credentials and know-how are helping other Omnicom networks in China deliver their own specialized marketing services to healthcare clients. The formalization of our relationship can only help speed our total growth," added Stark.
Jiang Song, Managing Director of Consultech, said, "Our decision to
join Omnicom opens a new era of development for us. Our deep understanding
of the Chinese healthcare market and extensive experience in consulting and
marketing communications combined with Omnicom's global resources and
networks further e
'/>"/>
| SOURCE Omnicom Group Inc. Copyright©2007 PR Newswire. All rights reserved |